A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Clinical trial NCT05328115 · COMPLETED

Trial details

NCT number: NCT05328115
Sponsor: Alzinova AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Dementia Alzheimers Dementia, Mild

Start date: 2021-09-30
Primary completion: 2025-01-27
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.